Published in Ann Pediatr (Paris) on September 01, 1977
NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell (2001) 2.42
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12
Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int (1975) 1.59
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55
Genetic heterogeneity of Alport syndrome. Kidney Int (1985) 1.55
Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet (1998) 1.54
Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine? Lancet (1994) 1.53
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature. Cancer (1996) 1.51
Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol (2001) 1.46
A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum Mol Genet (1997) 1.44
Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet (1996) 1.42
Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am J Pathol (2000) 1.37
The significance of pure diffuse mesangial proliferation in idiopathic nephrotic syndrome. Clin Nephrol (1978) 1.35
Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25
Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases. Clin Nephrol (1974) 1.21
Long-term outcome of idiopathic pulmonary hemosiderosis in children. Medicine (Baltimore) (2000) 1.20
Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet (1996) 1.20
The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): a distinctive glomerular lesion--report of 10 cases. Clin Nephrol (1985) 1.16
Meckel-Grüber syndrome: sonography and pathology. Ultrasound Obstet Gynecol (2006) 1.14
Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population. Pediatr Nephrol (1996) 1.14
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet (1998) 1.13
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol (2008) 1.13
PAX2 mutations in renal-coloboma syndrome: mutational hotspot and germline mosaicism. Eur J Hum Genet (2000) 1.10
Hypomelanosis of Ito (incontinentia pigmenti achromians) and mosaicism for a microdeletion of 15q1. Hum Genet (1986) 1.09
Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet (1995) 1.07
Deletion of mitochondrial DNA in patient with chronic tubulointerstitial nephritis. J Pediatr (1995) 1.06
Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN) Clin Immunol Immunopathol (1978) 1.05
Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys. Kidney Int (1984) 1.05
WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol (1999) 1.04
Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med (2001) 1.03
UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta (1991) 1.03
Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet (1992) 1.03
PAX2 mutations in oligomeganephronia. Kidney Int (2001) 1.03
Renin biosynthesis by human tumoral juxtaglomerular cells. Evidences for a renin precursor. J Clin Invest (1984) 1.02
WT1 splice-site mutations are rarely associated with primary steroid-resistant focal and segmental glomerulosclerosis. Kidney Int (2000) 1.02
Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int (1989) 0.99
Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet (2001) 0.99
Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia). Pediatr Nephrol (1987) 0.98
Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma. Anticancer Res (1995) 0.97
Nephrotic syndrome associated with T-cell lymphoma. Cancer (1981) 0.97
Diffuse leiomyomatosis associated with X-linked Alport syndrome: extracellular matrix study using immunohistochemistry and in situ hybridization. Lab Invest (1997) 0.97
Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol Necker Hosp (1981) 0.95
Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int (1998) 0.93
Importance of age and methotrexate dosage: prognosis in children and young adults with high-grade osteosarcomas. Biomed Pharmacother (1988) 0.93
Oxidative modifications of low-density lipoproteins (LDL) by the human endothelial cell line EA.hy 926. Experientia (1996) 0.92
Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. J Photochem Photobiol B (1993) 0.92
[Hereditary ornithine-carbamyl-transferase deficiency with qualitative enzyme abnormality. Report of a form with neonatal revelation and fatal course in a boy]. Arch Fr Pediatr (1973) 0.92
Genetics of the nephrotic syndrome. Curr Opin Pediatr (2000) 0.92
Distribution of extracellular matrix glycoproteins during normal development of human kidney. An immunohistochemical study. Lab Invest (1986) 0.91
Renal abnormalities in the Bardet-Biedl syndrome. Int J Pediatr Nephrol (1982) 0.91
Effect of various protein diets on growth, renal function, and survival of uremic rats. Kidney Int (1979) 0.91
Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochem Biophys Res Commun (2000) 0.91
Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases. Clin Nephrol (1990) 0.91
Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun (1999) 0.90
Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome. Clin Nephrol (1996) 0.90
Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus (2010) 0.90
Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis. Nephrologie (2000) 0.90
Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr (1981) 0.90
Alteration of the endocytotic pathway by photosensitization with fluoroquinolones. Photochem Photobiol (2000) 0.89
Oligomeganephronic renal hypoplasia. Adv Nephrol Necker Hosp (1997) 0.88
Ontogenesis of angiotensin-I converting enzyme in human kidney. Kidney Int (1987) 0.88
Ocular changes in long-term evolution of infantile cystinosis. Ophthalmic Paediatr Genet (1987) 0.88
Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol (1994) 0.88
[Congenital or childhood nephrotic syndrome with diffuse mesangial sclerosis]. Ann Pediatr (Paris) (1990) 0.88
Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. Am J Pathol (2000) 0.87
Extramembranous glomerulonephritis in children: report of 50 cases. J Pediatr (1973) 0.87
Spatiotemporal expression of molecules associated with junctional complexes during the in vivo maturation of renal podocytes. Int J Dev Biol (1994) 0.86
Renal failure from mitochondrial cytopathies. Nephron (1997) 0.86
Refined mapping of a gene (NPH1) causing familial juvenile nephronophthisis and evidence for genetic heterogeneity. Genomics (1994) 0.86
Crescentic glomerulonephritis in hyper IgD syndrome. Pediatr Nephrol (1999) 0.86
Prenatal diagnosis of bilateral isolated fetal hyperechogenic kidneys. Is it possible to predict long term outcome? BJOG (2002) 0.86
Diffuse mesangial sclerosis: a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol Necker Hosp (1993) 0.86
Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region. Cytogenet Cell Genet (1997) 0.86
Intra and intermolecular charge effects on the reaction of the superoxide radical anion with semi-oxidized tryptophan in peptides and N-acetyl tryptophan. Free Radic Res (1998) 0.86
Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang (1997) 0.86
[Recurrent pleurisy during temporal arteritis]. Poumon Coeur (1967) 0.86
In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett (1986) 0.86
Oxidized LDL activates STAT1 and STAT3 transcription factors: possible involvement of reactive oxygen species. FEBS Lett (1999) 0.86
Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis (1991) 0.85
Distribution of alpha-integrin subunits in fetal polycystic kidney diseases. Pediatr Nephrol (1997) 0.85
Deletion of the mitochondrial DNA in a case of de Toni-Debré-Fanconi syndrome and Pearson syndrome. Pediatr Nephrol (1994) 0.85
Expanding prostheses in conservative surgery for lower limb sarcoma. Int Orthop (1998) 0.85
UV-A irradiation induces a decrease in the mitochondrial respiratory activity of human NCTC 2544 keratinocytes. Free Radic Res (2001) 0.85
Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. Pediatr Nephrol (2004) 0.85
Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children (Berger's disease). Clin Nephrol (1974) 0.85
Renal allografts in cystinosis and mesangial demography. Clin Nephrol (1989) 0.85
Collagen distribution in human membranous glomerulonephritis. Pediatr Nephrol (1996) 0.85
Photodecontamination of blood components: advantages and drawbacks. Clin Hemorheol Microcirc (1998) 0.85
Late symptoms in infantile cystinosis. Pediatr Nephrol (1987) 0.84
Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus. Am J Pathol (1998) 0.84
Subcellular localization of and photosensitization by protoporphyrin IXhuman keratinocytes and fibroblasts cultivated with 5-aminolevulinic acid. Photochem Photobiol (1995) 0.84
Lovastatin enhances the photocytotoxicity of UVA radiation towards cultured N.C.T.C. 2544 human keratinocytes: prevention by cholesterol supplementation and by a cathepsin inhibitor. Biochem J (1995) 0.84
Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett (1996) 0.84
Clinicopathologic correlations in the nephrotic syndrome. Paediatrician (1979) 0.84
Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis. Fetal Diagn Ther (2001) 0.84
Glomerular extracellular matrix and growth factors in diffuse mesangial sclerosis. Pediatr Nephrol (2001) 0.84